AbioMed: Morgan Stanley upgrades to equal-weight from underweight. PT up 0.6% to $380.
Advanced Energy: Benchmark Company lowers PT to $90 from $110. Maintains buy rating.
Bio-Techne: Benchmark Company lowers target to $480 from $540. Maintains buy rating.
Blucora: Benchmark Company rai…
© MarketScreener.com 2022
previous post